We are live on
!
Find out more
BFM
Boston Financial Management Portfolio holdings
AUM
$3.31B
1-Year Est. Return
19.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$729M
AUM Growth
+$63.7M
(+9.6%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
28.18%
Holding
206
New
12
Increased
105
Reduced
63
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$1.85M |
| 2 |
Oneok
OKE
|
+$1.67M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.46M |
| 4 |
Cognizant
CTSH
|
+$1.22M |
| 5 |
Adobe
ADBE
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.76M |
| 2 |
IBM
IBM
|
+$3.53M |
| 3 |
Myriad Genetics
MYGN
|
+$1.31M |
| 4 |
Target
TGT
|
+$1.13M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.98% |
| 2 | Industrials | 11.55% |
| 3 | Energy | 11.36% |
| 4 | Consumer Staples | 10.91% |
| 5 | Technology | 10.25% |
Similar funds
CANY
MWM
CCM
ECG
LSAG
KL
WP
RDIA
Boston Financial Management's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Financial Management held 206 positions worth $729M, up 9.6% from $666M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Boston Financial Management's Q4 2013 filing shows 12 new, 105 increased, 63 reduced and 2 closed positions. Its largest new stake was American Tower: 23,815 shares worth $1.9M. The largest sale was Pfizer, an estimated $6.76M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Energy.
- Boston Financial Management's largest Q4 2013 buy was American Tower: 23,815 shares worth $1.9M.
- Boston Financial Management added most to Oneok in Q4 2013, an estimated $1.67M increase.
- Boston Financial Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $6.76M.
- Boston Financial Management fully exited Myriad Genetics in Q4 2013, selling an estimated $1.31M.
- Boston Financial Management's ten largest holdings make up 28% of its $729M portfolio in Q4 2013.
- Boston Financial Management opened 12 new positions and closed 2 in Q4 2013.
- Boston Financial Management's portfolio value rose 9.6% quarter-over-quarter to $729M.
Based on Boston Financial Management's 13F filing for Q4 2013, filed 25 Feb 2014.